Barely Significant
← all excerpts

Comparative infection risk in CAR T vs bispecific antibodies in B-cell lymphoma: a systematic review and meta-analysis.

Blood Adv · 2025 · PMC12686707 · PMID 40590871

Europe PMCDOI
1
hedged sentence
0.0800
closest p · 1.6× alpha
0.0800
boldest claim

The sentences

approached significanceP = .08so close (0.05 < p ≤ 0.1)
Subgroup analyses showed no significant difference between grade 3+ infection rates with CAR T vs BsAb therapy, though the relationship approached significance with a trend toward higher grade 3+ infections with BsAbs ( P = .08; Figure 2 B).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.